We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$80.4B
AUM Growth
-$11.7B
Cap. Flow
-$16B
Cap. Flow %
-19.95%
Top 10 Hldgs %
10.17%
Holding
3,937
New
591
Increased
1,069
Reduced
1,579
Closed
676

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$427M
2
ROKU icon
Roku
ROKU
+$393M
3
PARA
Paramount Global Class B
PARA
+$345M
4
T icon
AT&T
T
+$317M
5
QCOM icon
Qualcomm
QCOM
+$293M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$1.41B
2
PDD icon
Pinduoduo
PDD
+$755M
3
BMY icon
Bristol-Myers Squibb
BMY
+$716M
4
ABBV icon
AbbVie
ABBV
+$558M
5
CMG icon
Chipotle Mexican Grill
CMG
+$491M

Sector Composition

Rank Sector Weight
1 Healthcare 19.43%
2 Technology 17.52%
3 Communication Services 11.4%
4 Consumer Discretionary 10.59%
5 Consumer Staples 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMTR
3826
DELISTED
9 Meters Biopharma
NMTR
-31,499
Closed -$541K
NYMX
3827
DELISTED
Nymox Pharmaceutical Corp
NYMX
-67,564
Closed -$168K
BLU
3828
DELISTED
BELLUS Health Inc.
BLU
-56,400
Closed -$173K
HEXO
3829
DELISTED
HEXO Corp. Common Shares
HEXO
-45,538
Closed -$2.35M
BLCM
3830
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-26,631
Closed -$94K
AQUA
3831
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
-322,278
Closed -$8.7M
SEAC
3832
DELISTED
Seachange International Inc
SEAC
-4,327
Closed -$121K
ABB
3833
DELISTED
ABB Ltd
ABB
-148,500
Closed -$4.15M
AUD
3834
DELISTED
Audacy, Inc.
AUD
-222,500
Closed -$550K
IMV
3835
DELISTED
IMV Inc. Common Shares
IMV
-11,010
Closed -$338K
EVOP
3836
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
-52,500
Closed -$1.42M
OBSV
3837
DELISTED
ObsEva SA Ordinary Shares
OBSV
-600,800
Closed -$1.25M
MYOV
3838
DELISTED
Myovant Sciences Ltd.
MYOV
-111,700
Closed -$3.08M
LHCG
3839
DELISTED
LHC Group LLC
LHCG
-35,369
Closed -$7.54M
ATNX
3840
DELISTED
Athenex, Inc. Common Stock
ATNX
-8,480
Closed -$1.88M
AHPI
3841
DELISTED
Allied Healthcare Products
AHPI
-95,665
Closed -$466K
BNFT
3842
DELISTED
Benefitfocus, Inc.
BNFT
-111,554
Closed -$1.61M
OYST
3843
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
-30,639
Closed -$577K
NH
3844
DELISTED
NantHealth, Inc
NH
-18,933
Closed -$917K
ELOX
3845
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
-993
Closed -$158K
STON
3846
DELISTED
StoneMor Inc.
STON
-28,288
Closed -$74K
PHAS
3847
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
-83,400
Closed -$280K
CCXI
3848
DELISTED
ChemoCentryx, Inc.
CCXI
-66,100
Closed -$4.09M
EXTN
3849
DELISTED
Exterran Corporation
EXTN
-229,100
Closed -$1.01M
ZEAL
3850
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
-17,205
Closed -$618K

Similar funds

Renaissance Technologies's Q1 2021 Portfolio in Review

As of Q1 2021, Renaissance Technologies held 3,937 positions worth $80.4B, down 13% from $92.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Renaissance Technologies withdrew a net $16B in Q1 2021, closing 676 positions and reducing 1,579 holdings. Its most notable exit was Micron Technology, an estimated $252M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Renaissance Technologies opened a new position in Paramount Global Class B worth $255M.

  • Renaissance Technologies's largest Q1 2021 buy was Paramount Global Class B: 5,644,997 shares worth $255M.
  • Renaissance Technologies added most to Tesla in Q1 2021, an estimated $427M increase.
  • Renaissance Technologies's biggest Q1 2021 reduction was Baidu, cutting an estimated $1.41B.
  • Renaissance Technologies fully exited Micron Technology in Q1 2021, selling an estimated $252M.
  • Renaissance Technologies's ten largest holdings make up 10% of its $80.4B portfolio in Q1 2021.
  • Renaissance Technologies opened 591 new positions and closed 676 in Q1 2021.
  • Renaissance Technologies's portfolio value fell 13% quarter-over-quarter to $80.4B.

Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.